FDA COX-2 Review Will Include Input From Furberg, Full Rx Safety Advisory Cmte.

After initially being asked not to appear at the meeting, Wake Forest's Furberg is formally re-invited to participate at the Feb 16-18 advisory committee meeting. FDA first invited only two members of the drug safety committee but has expanded its invitation to the full committee.